Skip to main content

Medtronic plc company profile

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026

About Medtronic plc

Medtronic plc is a healthcare technology company headquartered in Galway, Ireland, founded in 1949. It develops, manufactures, distributes, and sells device-based medical therapies and services through three reportable segments: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio. Cardiovascular products include cardiac rhythm devices, cardiac ablation systems, structural heart and aortic products, and coronary and peripheral vascular products. Neuroscience products include spine and cranial technologies, neurovascular and ENT products, and neuromodulation systems. Medical Surgical products include surgical and endoscopy devices and patient monitoring and airway management products. The company sells to hospitals, physicians, clinicians, and patients, through direct sales representatives and third parties, in more than 150 countries.

A summary of the business section of the company's latest annual report, filed 18 Jun 2026.

Company facts

TickerMDT · NYSE
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends24 April
Reporting currencyUSD
CIK1613103
Latest annual report10-K, filed 18 Jun 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Geoffrey S. MarthaChairman and CEO · Director2.5MSale under a 10b5-1 plan, 15 Oct 2026
Brett WallEVP & Pres Neuroscience556KOption exercise, 26 May 2026
Michael MarinaroPresident461KGrant or award, 2 Nov 2026
Kendall J. PowellDirector51.6KShares withheld for tax, 28 Apr 2026
Randall J. Hogan, IIIDirector49.0KShares withheld for tax, 28 Apr 2026
Craig ArnoldDirector42.2KShares withheld for tax, 28 Apr 2026
Scott C. DonnellyDirector24.3KShares withheld for tax, 28 Apr 2026
Elizabeth G. Nabel, M.D.Director19.6KShares withheld for tax, 28 Apr 2026
Michelle QuinnEVP, GC and Secretary13.1KGrant or award, 3 Aug 2026
Kevin E. LoftonDirector10.2KCode J, 15 Oct 2026
Lidia L. FonsecaDirector7.7KShares withheld for tax, 28 Apr 2026
William R. JellisonDirector6.5KGrant or award, 27 Apr 2026
Gregory P. LewisDirector5.8KShares withheld for tax, 28 Apr 2026
Joon S. Lee, M.D.Director1.8KGrant or award, 27 Apr 2026
John P. GroetelaarsDirector1.5KGrant or award, 27 Apr 2026
KIIL HARRY SKIPEVP & President Cardiovascular—Open-market sale, 16 Sep 2026
Blomquist Denise L.Chief Accounting Officer—Gift, 15 Sep 2026
Thompson KweliEVP & President, Neuroscience—Grant or award, 3 Aug 2026
Pieton ThierryEVP & Chief Financial Officer—Grant or award, 3 Aug 2026
Walter Matthew R.SVP, Chief HR Officer—Grant or award, 3 Aug 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

MDT in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.